MDBriefCase will be unavailable due to maintenance from Sunday, January 14 11PM to Monday, January 15 1AM ET.
Welcome
In the ever-evolving landscape of public health, one constant remains: the critical importance of influenza vaccination. This powerful tool continues to play a vital role in reducing outbreaks of endemic influenza infection, particularly among one of our most vulnerable populations – children.
As we approach the 2022-2023 influenza season, physicians and pharmacists find themselves at the forefront of the fight against the flu. Their role? Stay informed, confident, and ready to apply the latest recommendations for pediatric influenza immunization.
The Power of Knowledge: For Physicians
Physicians, as trusted caregivers and medical advisors, your role in preventing influenza among pediatric patients is paramount. Our course, “Evaluating Pediatric Influenza Vaccines in 2022–2023 — Providing Optimal Protection for the Pediatric Population,” is designed to amplify your knowledge and confidence in this area.
In addition to a comprehensive summary of the key National Advisory Committee on Immunization (NACI) recommendations, the course offers an in-depth exploration of the currently marketed vaccines in Canada. You’ll gain insights into the unique benefits and potential drawbacks of each vaccine, helping you make informed decisions that best serve your young patients.
The course also delves into real-world case studies, offering a practical understanding of how to apply the NACI recommendations in various scenarios. You’ll also engage with peers and experts in the field, fostering a collaborative learning environment.
Ready to get started? Access the course here.
The Role of Pharmacists
Pharmacists, your role extends beyond the dispensing of medication. You are educators, advocates, and a critical point of contact for families navigating their health concerns – this makes your role in promoting and administering influenza vaccinations all the more crucial.
Our pharmacist-specific course, “Evaluating Pediatric Influenza Vaccines in 2022–2023 — Providing Optimal Protection for the Pediatric Population,” provides the same foundational knowledge shared with physicians, ensuring a unified approach across healthcare professionals.
But we also understand the unique challenges and opportunities you face. That’s why the course includes modules on effective patient communication strategies, addressing common vaccination concerns, and tips for managing your vaccine inventory efficiently.
Like the physicians’ course, you’ll explore real-world case studies and engage in discussions with peers and experts, enriching your learning experience.
By enhancing your knowledge and skills, you can ensure you’re not only dispensing medication but also invaluable advice, reassurance, and protection against influenza for your youngest patients.
Access the course here.
United in the Fight Against Flu
As healthcare professionals, physicians and pharmacists are pillars of trust and sources of critical information for patients. These courses aim to equip you with the knowledge and confidence needed to provide the highest level of care, specifically in the realm of pediatric influenza immunization.
Join us in this life-saving work. Sign up for these free courses today and let’s ensure the upcoming influenza season sees the power of informed, confident healthcare professionals providing optimal protection for our pediatric population. Together, we can make a difference in the fight against influenza.
199 Bay Street #4000, Toronto,
ON M5L 1A9
In submitting your work (the “Work”) for potential posting on the MDBriefCase Healthcare Leadership Lab website (the “Website”), you (“You”) expressly agree to the following:
Review: MDBriefCase is pleased to consider the publication of Your Work on the Website. The suitability of the Work for posting shall be determined by MDBRiefCase at its sole discretion. Nothing herein shall obligate MDBriefcase to post or otherwise publish the Work, or the maintain its posting in future.
Editing; Identification: MDBriefcase shall have the right to edit the Work to conform to our standards of style, technological requirements, language usage, grammar and punctuation, provided that the meaning of the Work is not materially altered. If posted, You will be identified as the author of the Work, or co-author if applicable.
Grant of Rights: As a condition of publication and for no monetary compensation, You hereby grant to MDBriefCase the following rights to the Work in any and all media whether now existing or hereafter developed, including print and electronic/digital formats: (1) the exclusive right of first publication worldwide; (2) the perpetual non-exclusive worldwide right to publish, reproduce, distribute, sell, adapt, perform, display, sublicense, and create derivative works, alone or in conjunction with other materials; (3) the perpetual non-exclusive worldwide right to use the Work, or any part thereof, in any other publication produced by MDBriefCase and/or on MDBriefCase’s website; and (4) the perpetual non-exclusive worldwide right to use the Work to promote and publicize MDBriefCase or its publications. The grant of rights survives termination or expiration of this Agreement.
Warranty: You warrant that the Work is original with You and that it is not subject to any third party copyright; that You have authority to grant the rights in this Agreement; that publication of the Work will not libel anyone or infringe on or invade the rights of others; that You have full power and authority to enter into this Agreement; that the Work has not been published elsewhere in whole or in part; and that You have obtained permission from the copyright owner consistent with this Agreement for any third party copyrighted material in the Work. This warranty survives termination or expiration of this Agreement.
Thank you for your interest in writing an article for the MDBriefCase Healthcare Leadership Lab website.
The Healthcare Leadership Lab welcomes submissions on all topics relevant to leaders in healthcare. Our topics include Leading in Healthcare, Leadership Lessons from COVID-19 and others. We prioritize stories that provide leadership advice to executives and managers in healthcare companies, offer actionable strategies for executing successful projects, and provide interesting angles on current healthcare topics. Submissions must be original work of the authors and unpublished. When submitting, authors represent that they have included no material that is in violation of the rights of any other person or entity.
Articles must be educational and non-promotional. If they mention the author’s company or any of the company’s products or services by name within the text, such mention should be very limited and used for reference only, not for promotion. (For example, an author might cite a survey conducted by his company but not describe his company’s product as a solution to a business problem.) Articles will be edited for clarity, style and brevity. The final headline is determined by the editor.
Guest articles for the MDBriefCase Healthcare Leadership Lab may run between 500 and 1000 words.
MDBriefCase reserves the right to accept or reject any submission and the right to condition acceptance upon revision of material to conform to its criteria.
There is no payment for contributed articles. However, MDBriefCase will give the author a byline. Authors are invited to link to the article on personal websites, corporate websites and social media platforms.
Each author understands and agrees that any submission accepted for posting is provided subject to MDBriefCase’s Author Agreement.
